Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Ligand Pharmaceuticals, Inc. (LGND) · oqro.io/stocks/LGND · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
A Ligand Pharmaceuticals director told the SEC about a plan to sell $960K of Ligand Pharmaceuticals shares around Nov 10, 2026. The shares were not acquired as compensation. That is a tiny part of all Ligand Pharmaceuticals shares.
A Ligand Pharmaceuticals director told the SEC about a plan to sell $90K of Ligand Pharmaceuticals shares around Nov 4, 2026. The shares were not acquired as compensation.
A Ligand Pharmaceuticals director told the SEC about a plan to sell $222K of Ligand Pharmaceuticals shares around Nov 2, 2026. The shares were not acquired as compensation.
A Ligand Pharmaceuticals director told the SEC about a plan to sell $65K of Ligand Pharmaceuticals shares around Oct 30, 2026. The shares were not acquired as compensation.
0 open-market purchases and 34 open-market sales by insiders of LGND between Jan 27, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 29, 2026. The data provider lists the next release for Feb 24, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Martine Zimmermann, Director, Nov 12, 2026, about $636K. Sold 14 days after the company's previous earnings release on 2026-10-29Form 4
John W Kozarich, Director, Nov 12, 2026, about $163K. Sold 14 days after the company's previous earnings release on 2026-10-29Form 4
Jason Aryeh, Director, Nov 10, 2026, about $160K. Sold 12 days after the company's previous earnings release on 2026-10-29Form 4
Jason Aryeh, Director, Nov 10, 2026, about $160K. Sold 12 days after the company's previous earnings release on 2026-10-29Form 4
, Director, Nov 10, 2026, about $3.2K. Sold 12 days after the company's previous earnings release on 2026-10-29
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies